YOLFTbeta
Arcticzymes Technologies ASA

Arcticzymes Technologies ASA

AZT · OL · Healthcare / Biotechnology

21.60NOK-1.10 (-4.85%)

Price History

Full chart

Market Stats

Previous Close22.70
Open22.70
Day Range21.40 – 22.70
52-Week Range18.30 – 31.40
Volume96.04K
Market Cap1.02B
P/E (TTM)66.33
Forward P/E39.37
EPS0.30
Dividend Yield0.00%
Beta0.57
50-Day Avg20.37
200-Day Avg20.83

About

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools market, and biomanufacturing markets. It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Michael Benjamin Akoh
  • Employees50
  • HeadquartersSykehusveien 23, Tromsø, Norway, 9294, Norway
  • Websitehttps://www.arcticzymes.com

Leadership

  • Mr. Michael Benjamin AkohChief Executive Officer · b. 1973
  • Mr. Borge SorvollChief Financial Officer · b. 1975
  • Dr. Marit Sjo LorentzenVice President of Operations · b. 1968
  • Mr. Paul Blackburn Ph.D.C.C.O · b. 1974
  • Mr. Steve DeyGlobal Director of Product Management & Marketing

Financials

Income Statement

Currency: NOK2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.97M72.33M147.20M70.04M72.97M73.22M51.70M24.07M25.91M23.03M21.48M22.11M33.03M53.28M71.90M66.69M66.77M77.25M93.45M127.97M136.97M118.94M104.35M112.62M
Growth (%)-+937.75%+103.53%-52.42%+4.19%+0.33%-29.39%-53.44%+7.62%-11.10%-6.76%+2.95%+49.38%+61.33%+34.95%-7.26%+0.12%+15.69%+20.97%+36.94%+7.03%-13.16%-12.26%+7.92%
Cost of Revenue1.41M15.13M13.16M14.58M15.21M16.20M4.86M1.70M1.69M1.88M1.78M2.51M11.04M16.20M26.74M21.93M19.37M18.90M1.13M3.88M5.18M5.93M5.98M4.68M
Gross Profit5.56M57.20M134.05M55.46M57.77M57.02M46.85M22.37M24.22M21.15M19.70M19.60M21.99M37.08M45.17M44.76M47.40M58.35M92.32M124.08M131.79M113.01M98.37M107.94M
Gross Margin79.82%79.08%91.06%79.18%79.16%77.87%90.61%92.93%93.48%91.85%91.72%88.66%66.57%69.59%62.82%67.12%71.00%75.53%98.79%96.96%96.22%95.02%94.27%95.84%
Operating Expense00-058.10M0138.16M107.50M53.50M42.35M44.20M43.78M46.42M55.57M65.39M69.67M61.57M64.10M49.52M65.65M95.32M97.27M99.81M105.12M
Operating Income5.56M57.20M-55.46M-334.00K57.02M-91.31M-85.12M-29.28M-21.20M-24.50M-24.18M-24.43M-18.49M-20.23M-24.91M-14.17M-5.76M42.79M58.43M36.47M15.75M-1.44M2.81M
Operating Margin79.82%79.08%-79.18%-0.46%77.87%-176.61%-353.58%-113.02%-92.02%-114.10%-109.35%-73.97%-34.70%-28.13%-37.36%-21.22%-7.45%45.79%45.66%26.63%13.24%-1.38%2.50%
EBITDA-155.37K-5.46M4.58M-11.81M-11.63M-9.52M-52.98M-65.68M-25.60M-17.50M-22.14M-20.58M-19.53M-14.42M-18.57M-22.27M-11.71M-506.00K60.56M62.89M47.66M31.64M17.51M21.43M
EBITDA Margin-2.23%-7.55%3.11%-16.86%-15.94%-13.01%-102.47%-272.81%-98.80%-76.00%-103.12%-93.10%-59.13%-27.06%-25.82%-33.39%-17.53%-0.66%64.81%49.14%34.80%26.60%16.78%19.03%
Net Income-642.53K-9.84M--15.45M-26.65M-18.66M-52.18M-99.37M-28.54M-20.10M-24.32M-22.89M-21.99M-17.34M-20.48M-24.94M-13.99M-6.39M83.12M46.38M32.86M19.43M8.47M9.88M
Net Income Margin-9.22%-13.60%--22.05%-36.53%-25.49%-100.92%-412.76%-110.16%-87.28%-113.24%-103.53%-66.59%-32.55%-28.48%-37.40%-20.95%-8.27%88.95%36.24%23.99%16.33%8.12%8.77%
R&D--4.02M---------------------
R&D as % of Total Revenue--2.73%---------------------
Interest Expense00000000000000731.00K00797.00K631.00K694.00K499.00K497.00K349.00K275.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.02%0.00%0.00%1.03%0.68%0.54%0.36%0.42%0.33%0.24%

Balance Sheet

Currency: NOK2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.63M65.49M58.58M140.59M123.75M219.54M187.77M92.20M68.98M56.44M32.24M53.78M111.13M101.07M85.83M61.68M68.02M77.61M221.91M284.11M319.04M339.32M344.26M361.41M
Total Liabilities-59.59M8.73M9.40M12.84M18.04M15.50M28.49M31.05M32.59M10.61M10.33M11.26M12.26M14.32M17.75M16.87M14.12M31.13M25.58M39.27M34.30M30.03M20.91M22.94M
Total Equity67.23M56.75M49.18M127.76M105.71M204.04M159.27M61.15M36.39M44.16M20.73M41.68M98.43M86.26M67.51M44.10M53.02M45.14M194.37M244.84M284.74M309.30M323.35M338.47M
Cash2.52M14.06M13.04M94.88M63.97M151.70M124.59M49.65M43.36M36.08M6.73M32.54M86.40M76.89M56.21M28.58M31.03M29.62M138.99M198.78M242.03M178.61M170.95M187.78M
Total Debt-----------------16.02M11.96M17.57M----
Net Debt-2.52M-14.06M-13.04M-94.88M-63.97M-151.70M-124.59M-49.65M-43.36M-36.08M-6.73M-32.54M-86.40M-76.89M-56.21M-28.58M-31.03M-13.60M-127.03M-181.21M----

Cash Flow

Currency: NOK2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-189.58K-5.10M-3.05M-8.47M-32.59M--65.66M-89.00M-24.96M-10.81M-24.58M-17.39M-21.20M-12.89M-19.28M-22.06M-18.28M3.96M46.93M74.97M58.10M28.24M1.66M25.81M
Investing Cash Flow---------------1.35M-5.02M-2.70M-1.10M64.85M-11.56M-12.44M-21.02M-9.87M-5.14M
Financing Cash Flow--440.00K48.00K84.69M4.04M116.20M-45.00K-53.00K20.05M8.10M-33.00K43.22M77.70M4.44M-46.00K18.96M22.05M-3.24M-3.26M-3.16M-1.92M-1.32M-1.73M-3.84M
Capital Expenditure1.31M3.80M1.34M00866.00K2.35M1.25M1.79M5.49M2.15M1.63M1.93M1.57M1.35M5.05M2.71M1.10M1.91M11.60M4.81M20.47M9.52M3.64M
Free Cash Flow-1.50M-8.91M-4.39M-8.47M-32.59M--68.01M-90.25M-26.75M-16.30M-26.73M-19.01M-23.13M-14.46M-20.63M-27.11M-20.99M2.87M45.02M63.37M45.66M7.77M-7.86M22.17M
FCF to OCF793.18%174.58%144.03%100.00%100.00%-103.59%101.41%107.17%150.74%108.74%109.36%109.08%112.18%107.02%122.90%114.84%72.26%95.93%84.53%78.60%27.52%-473.96%85.89%

Earnings

Report DateOct 31, 2006May 9, 2007Oct 31, 2007Feb 28, 2008Aug 12, 2008May 15, 2009Aug 11, 2009Nov 13, 2009Feb 26, 2010May 11, 2010Aug 10, 2010Nov 12, 2010Feb 18, 2011May 13, 2011Aug 9, 2011Nov 9, 2011Feb 21, 2012May 7, 2012Aug 10, 2012Nov 6, 2012Feb 15, 2013May 6, 2013Aug 8, 2013Nov 1, 2013Feb 14, 2014Apr 29, 2014Aug 13, 2014Nov 5, 2014Feb 17, 2015May 5, 2015Aug 13, 2015Nov 2, 2015Feb 11, 2016Apr 19, 2016Aug 17, 2016Oct 26, 2016Feb 2, 2017Apr 27, 2017Aug 17, 2017Oct 19, 2017Feb 1, 2018Apr 26, 2018Aug 16, 2018Oct 18, 2018Jan 30, 2019Apr 30, 2019Aug 15, 2019Oct 24, 2019Jan 30, 2020Apr 23, 2020Aug 19, 2020Oct 22, 2020Jan 28, 2021Apr 22, 2021Aug 19, 2021Oct 28, 2021Jan 27, 2022Apr 28, 2022Aug 18, 2022Oct 27, 2022Feb 1, 2023May 4, 2023Aug 17, 2023Nov 2, 2023Feb 1, 2024May 8, 2024Aug 22, 2024Nov 6, 2024Feb 12, 2025May 8, 2025Aug 14, 2025Nov 6, 2025Feb 13, 2026May 7, 2026Aug 14, 2026Nov 5, 2026
EPS Estimate-0.10-0.50-0.40-0.30-0.40-1.10---1.30----------------------0.06-0.11-0.10-0.08--0.17-0.20-0.10--0.10-0.20-0.10--0.10--0.10-0.100.10------0.23-0.090.260.350.170.170.040.150.090.050.110.070.040.07-0.000.030.020.040.050.020.110.07
EPS Actual-0.40-0.24-0.16-0.22-0.52-0.68-0.85-1.24-2.22-0.53-0.24-0.33-0.08-0.10-0.17-0.18-0.22-0.16-0.20-0.23-0.24-0.17-0.12-0.12-0.17-0.19-0.06-0.14-0.12-0.07-0.03-0.11-0.18-0.09-0.05-0.14-0.19-0.10-0.11-0.18-0.17-0.15-0.10-0.01-0.04-0.11-0.04-0.010.020.280.530.190.740.390.100.130.280.410.170.050.020.100.110.120.040.060.07-0.030.06-0.060.070.060.130.010.10-
Surprise-300.00%52.00%60.00%26.67%-30.00%38.18%---70.77%---------------------50.00%0.00%-80.00%-12.50%-17.65%5.00%0.00%--80.00%15.00%-50.00%-90.00%--10.00%60.00%-110.00%-------56.52%244.44%7.69%17.14%0.00%-70.59%-50.00%-33.33%22.22%140.00%-63.64%-14.29%75.00%-142.86%1864.71%-300.00%250.00%50.00%160.00%-50.00%-9.09%-
TimingPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market--After-hours-----------------Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.02B
Enterprise Value816.84M
Trailing P/E66.33
Forward P/E39.37
Price / Sales7.62
Price / Book3.08
EPS0.30
Book Value6.79
Revenue (TTM)133.41M
Gross Profit (TTM)127.30M
EBITDA15.54M
Profit Margin11.54%
Operating Margin15.24%
Return on Equity4.57%
Return on Assets1.96%
Shares Outstanding51.07M
Shares Float42.17M
Beta0.57
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%